Molecular Biology of Squamous Cell Carcinoma of the Anus: A Comparison of HIV-Positive and HIV-Negative Patients

被引:0
|
作者
Pascal Gervaz
Dieter Hahnloser
Bruce G. Wolff
Sarah A. Anderson
Julie Cunningham
Robert W. Beart
Adam Klipfel
Lawrence Burgart
Stephen N. Thibodeau
机构
[1] Department of Colon and Rectal Surgery,Department of Laboratory Medicine and Pathology
[2] Mayo Clinic,Department of Colon and Rectal Surgery
[3] University of Southern California,undefined
来源
关键词
Anal cancer; biology; HIV; genes; HPV; loss of heterozygosity;
D O I
暂无
中图分类号
学科分类号
摘要
The molecular mechanisms involved in progression of squamous cell carcinoma of the anus (SCCA) are poorly elucidated, as well as the potential role of HIV infection. Loss of heterozygosity (LOH) is one of the mechanisms responsible for inactivation of tumor suppressor genes. We hypothesized that HIV-induced immunosuppression may contribute to an alternate molecular pathway in SCCA progression, through persistence of human papillomavirus infection within the anal canal. This study was undertaken to compare the molecular biology of SCCA in HIV-positive (HIV+) and HIV-negative (HIV-) patients. We retrieved tumor specimens from 18 HIV- and 10 HIV+ patients diagnosed with SCCA in two institutions. DNA from tumor and normal tissues was extracted and then amplified by polymerase chain reaction. LOH was investigated at 14 loci: three at 18q (DCC), two at 13q (Rb), three at 17p (p53), three at 11q, one at 2p, and two at 5q (APC). LOH was defined by a tumor DNA-to-normal tissue DNA ratio of >2. HIV+ patients were younger (36 ± 7 years versus 53 ± 13 years, P = 0.001) and showed a trend toward tumors of larger size (3.7 ± 1.6 cm versus 2.6 ± 1.5 cm, P = 0.09). The median CD4+ count in HIV+ patients at the time of diagnosis was 74 × 106/L (range, 5–900). The overall frequency of LOH was 17.3% (41 LOH of 236 informative loci). Tumors in HIV- patients were more likely to present LOH than were tumors in HIV+ patients (24.1% versus 6.6%, P = 0.0004). Differences between the two groups with regard to allelic losses were also observed at specific loci, such as 18q (41% [HIV-] versus 0% [HIV+], P = 0.05), 17p (43% versus 10%, P = 0.09), and 5q (33% versus 0%, P = 0.12). Consistent LOH on chromosomes 17p, 18q, 5q, and 11q were observed in HIV- patients with SCCA. By contrast, allelic losses at 17p, 5q, and 18q seem to be rare in tumors of HIV+ individuals. These data suggest that immunosuppression may promote SCCA progression through an alternate pathway and that persistence of HPV infection within the anal canal may play a central role in this process.
引用
下载
收藏
页码:1024 / 1031
页数:7
相关论文
共 50 条
  • [31] Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans
    Guest, J. L.
    Rentsch, C. T.
    Rimland, D.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2014, 26 (12): : 1490 - 1493
  • [32] HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients
    Kim, JH
    Sarani, B
    Orkin, BA
    Young, HA
    White, J
    Tannebaum, I
    Stein, S
    Bennett, B
    DISEASES OF THE COLON & RECTUM, 2001, 44 (10) : 1496 - 1502
  • [33] Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
    Nutt, Robert J.
    Clements, John L.
    Dean, William H.
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 2435 - 2440
  • [34] RENAL COMPLICATIONS OF AMPHOTERICIN-B IN HIV-POSITIVE AND HIV-NEGATIVE PATIENTS
    ANAND, A
    FEINFELD, D
    BROCAVICH, J
    GLATT, A
    CLINICAL RESEARCH, 1992, 40 (03): : A663 - A663
  • [35] Syphilis-related Ocular Inflammation in HIV-positive and HIV-negative Patients
    Ly, Victoria
    Elhusseiny, Abdelrahman M.
    Sallam, Ahmed B.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (05) : 1035 - 1040
  • [36] Infectious Disease Immunohistochemistry in Placentas from HIV-Positive and HIV-Negative Patients
    Schuetz, Audrey N.
    Guarner, Jeannette
    Packard, Michelle M.
    Zaki, Sherif R.
    Shehata, Bahig M.
    Opreas-Ilies, Gabriela
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2011, 14 (03) : 180 - 188
  • [37] Outcomes in HIV-Positive vs HIV-Negative Patients With Pneumocystis Jiroveci Pneumonia
    Kang, Mohleen
    Ezeonu, Chidinma
    Duma, Narjust
    Dominguez, Yulanka Castro
    Feurdean, Mirela
    CHEST, 2016, 150 (04) : 110A - 110A
  • [38] Etiological diagnostics of tuberculous pleurisy (PTB) in HIV-positive and HIV-negative patients
    Zhuravlev, Viacheslav
    Vladimirov, Kirill
    Kozlova, Nataliay
    Ivanov, Aleksandr
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [39] A comparative analysis of molecular genotypes of Mycobacterium tuberculosis isolates from HIV-positive and HIV-negative patients
    Singh, Jitendra
    Singh, Niti
    Suresh, Gayatri
    Srivastava, Rahul
    Aggarwal, Upasna
    Behera, Digamber
    Munisamy, Murali
    Malhotra, Anvita Gupta
    Singh, Sarman
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [40] Molecular epidemiology of Microsporidia among HIV-positive and HIV-negative patients in the Limpopo province, South Africa
    Samie, Amidou
    Maluleke, Rhulani Patricia
    Tanih, Nicoline
    ElBakri, Ali
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (05): : 710 - 718